稳心颗粒通过调控PTEN/Akt/mTOR通路减轻ISO诱导的心脏肥大OA
Wenxin granule attenuate ISO-induced cardiac hypertrophy by modulat-ing the PTEN/Akt/mTOR pathway
目的:探讨稳心颗粒对异丙肾上腺素(isoproterenol,ISO)诱导的小鼠心脏肥大作用机制.方法:将小鼠随机分为对照组、ISO组、稳心颗粒高、中、低剂量组,ISO皮下注射7.5 mg·kg-1·d-1诱导心脏肥大,连续14 d;稳心颗粒高、中、低剂量组在此基础上分别给予0.1 g/kg、0.05 g/kg、0.025 g/kg灌胃,采用超声心动图检测技术评估实验小鼠心功能指标;WGA染色、HE染色评估小鼠心脏组织病理改变.体外培养的H9c2细胞采用稳心颗粒(5 mg/mL)预处理2 h,再给予ISO(10 µmoL)处理构建心肌细胞肥大模型,采用MTT法检测细胞活力;RT-qPCR检测心脏肥大标志物心房钠尿肽(atrial natriuretic peptide,ANP)和脑钠尿肽(brain natriuretic peptide,BNP)的mRNA表达;Western blot检测小鼠心脏组织和大鼠心肌细胞相关蛋白表达.结果:动物实验中,与对照组相比,ISO组射血分数(ejection fraction,EF)、左室短轴缩短率(fractional shortening,FS)值降低(P<0.01),左心室内径舒张末期(left ventricular internal diameter at end-diastole,LVIDd)、左心室内径收缩末期(left ventricular internal diameter at end-sys-tole,LVIDs)、左心室后壁舒张末期厚度(left ventricular posterior wall thickness at end-diastole,LVPWd)、左心室后壁收缩末期厚度(left ventricular posterior wall thickness at end-systole,LVPWs)升高(P<0.05或P<0.01);RT-qPCR结果显示,与对照组相比,ISO组小鼠组织ANP、BNP的 mRNA升高(P<0.01);Western blot分析表明,与对照组相比,ISO组PTEN蛋白表达下降趋势(P<0.01),Akt和mTOR的磷酸化水平与其总蛋白比值均呈现显著上升趋势(P<0.01).细胞实验中,与对照组相比,ISO组细胞活力降低(P<0.01);细胞面积增大(P<0.01);RT-qPCR结果显示,与对照组相比,ISO组ANP和BNP的mRNA水平升高(P<0.01);Western blot分析表明,与对照组相比,ISO组PTEN蛋白表达下调(P<0.05),Akt和mTOR的磷酸化水平与其总蛋白比值均呈现显著上升趋势(P<0.01).动物实验中,与ISO组相比,稳心颗粒高剂量组可逆转上述指标;细胞实验中稳心颗粒也可逆转.此外,用特异性PTEN抑制剂VO-ohpic trihydrate(VO-ohpic)处理,逆转了稳心颗粒的作用.结论:稳心颗粒可显著抑制ISO所致的心脏肥大病理改变,该保护效应通过调控PTEN/Akt/mTOR信号转导通路而实现.
AIM:This study aimed to investigate the mechanism of Wenxin granules in isoproterenol(ISO)-induced cardiac hypertrophy in mice.METHODS:The mice were randomly divided into a control group,an ISO group,and high-,medium-,and low-dose Wenxin granule groups.ISO was administered subcutaneously at 7.5 mg·kg-1·d-1 for 14 consecutive days to induce myocardial hypertrophy.The high-,medium-,and low-dose Wenxin granule groups re-ceived 0.10 g/kg,0.05 g/kg,and 0.025 g/kg,respectively,by gavage.Cardiac function was evaluated using echocar-diography,while wheat germ agglutinin(WGA)staining and hematoxylin-eosin(HE)staining were performed to assess histopathological changes in myocardial tissue.In vitro,H9c2 cells were pretreated with Wenxin granules(5 mg/mL)for 2 h,followed by ISO(10 µmol)treatment to establish a cellular hypertrophy model.Cell viability was assessed using the MTT assay.The mRNA expression levels of the hypertrophic markers atrial natriuretic peptide(ANP)and brain natriuret-ic peptide(BNP)in mouse heart tissue and cultured cells were measured by RT-qPCR,while the expression of related pro-teins was determined by Western blot.RESULTS:In animal experiments,compared with the control group,the ISO group showed decreased ejection fraction(EF)and fractional shortening(FS)(P<0.01),along with increased left ven-tricular internal diameter at end-diastole(LVIDd),left ventricular internal diameter at end-systole(LVIDs),left ventricu-lar posterior wall thickness at end-diastole(LVPWd),and left ventricular posterior wall thickness at end-systole(LVP-Ws)(P<0.05 or P<0.01).RT-qPCR analysis revealed that the mRNA expression levels of ANP and BNP in myocardial tissue were significantly elevated in the ISO group(P<0.01).Western blot demonstrated reduced PTEN protein expres-sion and significantly increased phosphorylation levels of Akt and mTOR,as indicated by the ratios of phosphorylated to to-tal protein(P<0.01).In the cellular experiments,compared with the control group,the ISO group exhibited reduced cell viability and enlarged cell surface area(P<0.01).RT-qPCR results showed elevated ANP and BNP mRNA expression,while Western blot analysis revealed decreased PTEN expression and increased phosphorylation of Akt and mTOR.Com-pared with the ISO group,treatment with high-dose Wenxin granules reversed these pathological and molecular changes in both animal and cellular models(P<0.05 or P<0.01).Furthermore,treatment with the specific PTEN inhibitor VO-ohpic trihydrate(VO-ohpic)abolished the protective effects of Wenxin granules.CONCLUSION:Wenxin granules significant-ly inhibited ISO-induced pathological changes in cardiac hypertrophy,and this protective effect was achieved through mod-ulation of the PTEN/Akt/mTOR signaling pathway.
岳红叶;李厚君;刘佳璐;宿文慧;张淑杰;房振;陈彦波;孙志朋
山东第二医科大学药学院,山东 潍坊 261053山东第二医科大学药学院,山东 潍坊 261053山东第二医科大学药学院,山东 潍坊 261053山东第二医科大学药学院,山东 潍坊 261053山东第二医科大学临床医学院,山东 潍坊 261053潍坊市人民医院心脏重症与康复科,山东 潍坊 261000潍坊市人民医院心律失常科,山东 潍坊 261000山东第二医科大学药学院,山东 潍坊 261053
医药卫生
稳心颗粒心脏肥大异丙肾上腺素网络药理学
Wenxin granulescardiac hypertrophyisoprenalinenetwork pharmacology
《中国病理生理杂志》 2026 (1)
60-69,10
国家自然科学基金资助项目(No.82204391)
评论